412 related articles for article (PubMed ID: 19515760)
1. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
Lee SK; Harris J; Swanstrom R
J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
[TBL] [Abstract][Full Text] [Related]
2. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
3. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
5. A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.
Robinson BA; Reed JC; Geary CD; Swain JV; Lingappa JR
J Virol; 2014 May; 88(10):5718-41. PubMed ID: 24623418
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
7. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
Wiegers K; Rutter G; Kottler H; Tessmer U; Hohenberg H; Kräusslich HG
J Virol; 1998 Apr; 72(4):2846-54. PubMed ID: 9525604
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
9. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
Ristic N; Chin MP
Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
[TBL] [Abstract][Full Text] [Related]
10. Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.
Fontana J; Keller PW; Urano E; Ablan SD; Steven AC; Freed EO
J Virol; 2016 Jan; 90(2):972-8. PubMed ID: 26537676
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.
Tessmer U; Kräusslich HG
J Virol; 1998 Apr; 72(4):3459-63. PubMed ID: 9525682
[TBL] [Abstract][Full Text] [Related]
12. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.
van Maarseveen NM; Andersson D; Lepšík M; Fun A; Schipper PJ; de Jong D; Boucher CA; Nijhuis M
Retrovirology; 2012 Apr; 9():29. PubMed ID: 22462820
[TBL] [Abstract][Full Text] [Related]
14. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
15. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
[TBL] [Abstract][Full Text] [Related]
16. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
Cimarelli A; Luban J
J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.
Müller B; Anders M; Akiyama H; Welsch S; Glass B; Nikovics K; Clavel F; Tervo HM; Keppler OT; Kräusslich HG
J Biol Chem; 2009 Oct; 284(43):29692-703. PubMed ID: 19666477
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
19. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
Urano E; Timilsina U; Kaplan JA; Ablan S; Ghimire D; Pham P; Kuruppu N; Mandt R; Durell SR; Nitz TJ; Martin DE; Wild CT; Gaur R; Freed EO
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567982
[TBL] [Abstract][Full Text] [Related]
20. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
Pettit SC; Henderson GJ; Schiffer CA; Swanstrom R
J Virol; 2002 Oct; 76(20):10226-33. PubMed ID: 12239298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
